Skip to main content
Log in

Bilateral osteonecrosis of the femoral head in an adult man affected by congenital estrogen deficiency

  • Case Report
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Osteonecrosis of femoral head is related to different predisposing factors. The pathogenesis is not completely understood, but an ischemic impairment seems to be one of the major determinants of bone necrosis. The association of bilateral necrosis of femoral heads and congenital aromatase deficiency is here reported. The absence of estrogen activity, as well as the persistence of unfused epiphyses for a long period of life, may be involved in the determinism of bilateral necrosis of bone femoral heads. The possibility of development of bone necrosis in patients affected by congenital estrogen deficiency needs to be considered and magnetic resonance imaging can be a useful method for an early detection of this disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Froberg PK, Braunstein EM, Buckwalter KA. Osteonecrosis, transient osteoporosis, and transient bone marrow edema. Current concepts. Radiol Clin North Am 1996, 34: 273–91.

    PubMed  CAS  Google Scholar 

  2. Carani C, Qin K, Simoni M, et al. Effect of testosterone and estradiol in a man with aromatase deficiency. N Engl J Med 1997, 337: 91–5.

    Article  PubMed  CAS  Google Scholar 

  3. Rochira V, Faustini-Fustini M, Balestrieri A, Carani C. Estrogen replacement therapy in a man with congenital aromatase deficiency: effects of different doses of transdermal estradiol on bone mineral density and hormonal parameters. J Clin Endocrinol Metab 2000, 85: 1841–5.

    Article  PubMed  CAS  Google Scholar 

  4. Mont MA, Hungerford DS. Non-traumatic avascular necrosis of the femoral head. J Bone Joint Surg 1995, 77A: 459–74.

    Google Scholar 

  5. Bilezikian JP, Morishima A, Bell J, Grumbach MM. Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency. N Engl J Med 1998, 339: 599–603.

    Article  PubMed  CAS  Google Scholar 

  6. Barrett-Connor E, Mueller JE, Von Muhlen DG, Laughlin GA, Schneider DL, Sartoris DJ. Low levels of estradiol are associated with vertebral fractures in older men, but not women: the Rancho Bernardo Study. J Clin Endocrinol Metab 2000, 85: 219–23.

    PubMed  CAS  Google Scholar 

  7. Warren MP, Shane E, Lee MJ, et al. Femoral head collapse associated with anorexia nervosa in a 20 year old ballet dancer. Clin Orthop 1990, 251: 171–6.

    PubMed  Google Scholar 

  8. Gerber HP, Vu TH, Ryan AM, Kowalski J, Werb Z, Ferrara N. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 1999, 5: 623–8.

    Article  PubMed  CAS  Google Scholar 

  9. Hyder SM, Nawaz Z, Chiappetta C, Stancel GM. Identification of functional estrogen response elements in the gene coding for the potent angiogenic factor vascular endothelial growth factor. Cancer Res 2000, 60: 3183–90.

    PubMed  CAS  Google Scholar 

  10. Herrmann BL, Saller B, Janssen OE, et al. Impact of estrogen replacement therapy in a male with congenital aromatase deficiency caused by a novel mutation in the cyp19 gene. J Clin Endocrinol Metab 2002, 87: 5476–84.

    Article  PubMed  CAS  Google Scholar 

  11. Grumbach MM, Auchus RJ. Estrogen: consequences and implications of human mutations in synthesis and action. J Clin Endocrinol Metab 1999, 84: 4677–94.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Balestrieri, A., Madeo, B., Rochira, V. et al. Bilateral osteonecrosis of the femoral head in an adult man affected by congenital estrogen deficiency. J Endocrinol Invest 26, 762–764 (2003). https://doi.org/10.1007/BF03347361

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03347361

Key-words

Navigation